The inhibition of BAFF and APRIL using a soluble receptor, TACI-Ig or atacicept (SeronoMerck Inc.), in a culture of myeloma cell lines causes rapid cell death [44] and inhibits myeloma growth in a coculture system with osteoclasts [45]. Here, TNFSF13B is linked to plasma cell myeloma.